RSKD: the bull case, the bear case, and the verdict
Why the screener flagged it
- Unusual volume surge
- Revenue growth accelerating
- MACD bullish crossover
- Bollinger Band squeeze breakout
The bull case
Good morning. I've reviewed the comprehensive data package, and I want to address what I believe is a fundamentally pessimistic misinterpretation of Riskified's position. The bear thesis focuses on near-term profitability challenges and cash burn from buybacks, but this analysis misses the forest for the trees. Let me make the case for why RSKD is a genuine buy at current levels.
The bear analyst is correct that RSKD is currently unprofitable—but they're treating this as a permanent state rather than a deliberate strategic choice. Let me be direct: companies don't burn cash on aggressive buyback programs when they're in distress. They do it when management has confidence in near-term profitability.
Consider the evidence:
Q2 2026 Results (November 11 Catalyst)
- Revenue: $98.7M (up 21.8% YoY from $81.1M)
- Gross Profit: $44.97M (45.5% margin)
- Operating Loss: -$7.4M (but this is what we need to address)
- Critically: Net loss improved 78% sequentially from Q1 to Q2 (-$9.1M vs. -$4.4M)
The trend line is upward. The company is converging toward profitability, not diverging from it.
Here's what the bear misses: Operating cash flow of $13.3M in Q2 2026 means the company is generating cash from operations—it's just that operating expenses are still too high. This is a scaling problem, not a business model problem. SaaS companies regularly operate at negative net income while positive FCF because of how accounting works (stock-based comp, depreciation, etc.).
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The bear case
Good morning. I appreciate the bull's passion, but I need to deconstruct this argument methodically because it's built on selective interpretation of data, false comparisons, and dangerously optimistic assumptions that ignore the hard reality: RSKD is a company in financial distress masquerading as an inflection story.
Let me address this directly and forensically.
I. The bull commits the cardinal sin: confusing hope with evidence
The bull's core argument rests on a single proposition: "The company is converging toward profitability." This is asserted, not proven. Let's examine the actual evidence:
The Bull's "Improving Trajectory" Claim
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Trend |
|---|---|---|---|---|---|---|
| Revenue | $81.1M | $81.9M | $99.3M | $88.3M | $98.7M | Volatile, not clean |
| Net Income | -$11.6M | -$7.8M | +$5.76M | -$4.4M | -$9.1M | Reverting to loss |
| Operating Income | -$9.2M | -$6.8M | +$4.2M | -$3.1M | -$7.4M | Deteriorating |
| OpEx/Revenue | 58% | 59% | 51% | 60% | 53% | Volatile, not trending |
Here's what the bull doesn't want you to see: Q4 2025 was an anomaly—a single profitable quarter surrounded by losses. The company reverted to losses in Q1 and Q2 2026. The bull frames this as "improving trajectory," but the data shows oscillation, not convergence.
The Critical Red Flag: If the company were truly converging toward profitability, we would expect:
- ✗ Monotonic improvement in net income? NO—Q2 2026 loss worsened to -$9.1M
- ✗ Consistent OpEx/revenue decline? NO—it spiked to 60% in Q1, improved to 53% in Q2, but this is noise
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The research manager's call
Recommendation: Overweight
Rationale: This was a genuinely well-argued debate on both sides, so let me walk through how I weighed it.
Where the Bear landed punches
The bear made real, substantive points. The oscillation in profitarity across six quarters (profitable in Q4 2025, then back to losses in Q1 and Q2 2026) is a legitimate concern — it's not a clean linear convergence. The SBC-adjusted OCF argument is valid; stripping out roughly $8–9M in non-cash SBC does shrink true cash generation materially. The peer comp critique is also fair — comparing RSKD's forward P/E to Datadog and CrowdStrike, which are durably profitable with far higher FCF margins, is a category error. And the accelerating buyback program against a compressing cash runway is a legitimate governance concern, not easily dismissed.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
Stress-test your own thesis on RSKD (or any US stock)
Enter a ticker, your optional thesis, and your email. Twelve AI agents will argue the bull and bear case, test your reasoning, and email your 4-page PDF report.
Unlock the full trade plan & Trader desk
Stop loss and take profit levels, position sizing, the risk team's debate and the full transcript for RSKD are in Pro ($39/mo or $379/yr, 5/day). Or upgrade to Trader ($99/mo or $949/yr, 10/day) for live position tracking vs the S&P 500, price/stop email alerts, and weekly Monday AI thesis re-checks. Pro and Trader both include an Alpaca paper-trading order ticket.
Get Pro — $39/mo →Get Trader — $99/mo →5-Report Pack — $19 one-time →Founding Lifetime Pass — $499 (20 seats) →All RSKD debates and the latest verdict →
Other recent analyses
This page was generated automatically by HedgePick's AI agents from public market data. It is general information, not personalized investment advice, and not a recommendation to buy or sell any security. AI output can be wrong or out of date. HedgePick is not a registered investment adviser or broker-dealer. Do your own research and consider your own situation before trading.